Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

21081 - 21090 of 57753 results found

Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic...

Date
Thursday, September 28, 2023 - 4:00 AM
Description
INTRODUCTION: People who are immunocompromised have a poor biological response to vaccinations. This study aims to determine in patients with chronic lymphocytic leukaemia (CLL) if a 3-week pause in Bruton tyrosine kinase inhibitor therapy (BTKi)

Increased intra-pulmonary shunt and alveolar dead space post COVID-19

Date
Thursday, September 28, 2023 - 4:00 AM
Description
CONCLUSIONS: In our population, recovery from COVID-19 was associated with increased Q(S)/Q(t) in 37% of patients, increased V(D)/V(T) in 86%, and increased alveolar ventilation up to ~13 months post infection. NIH severity predicted Q(S)/Q(t) but